project id: TCGA-BLCA; case submitter id: TCGA-E7-A7DV; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.1; age at index: 44; days to birth: -16145; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1969; age at diagnosis: 16145; ajcc pathologic m: MX; ajcc pathologic n: N3; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 37.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 164; days to sample procurement: 0; initial weight: 1610.0; portion submitter id: TCGA-E7-A7DV-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 20.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 60.0; percent tumor nuclei: 92.0;